Search Results 1451-1460 of 25045 for oral

  1. An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease. Participation ...

  2. Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - Mayo Clinic

    This study will provide long-term, open-label data regarding the effect of continued long-term oral treprostinil therapy for the treatment of pulmonary ...

  3. Cycloserine (oral route) - Mayo Clinic

    Description. Cycloserine belongs to the family of medicines called antibiotics. It is used to treat tuberculosis (TB). When cycloserine is used for TB, ...

  4. Athlete's foot - Diagnosis and treatment - Mayo Clinic

    Or you might need both topical and oral medicine. Request an appointment. There is a problem with information submitted for this request. Review/update the ...

  5. Safety and Tolerability of GTX-104 Compared With Oral Nimodipine in Patients With aSAH - Mayo Clinic

    The purpose of this study is to deliver nimodipine via IV directly into the bloodstream and to determine if this is as safe and tolerable as oral nimodipine ...

  6. A Blanket Protocol to Study Oral Regorafenib in Patients with Selected Sarcoma Subtypes - Mayo Clinic

    Regorafenib might or might not slow down the growth of your tumor, or shrink your tumor. Regorafenib is approved in the United States to treat colon cancer and ...

  7. Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (oral route) - Mayo Clinic

    For oral dosage form (tablets):. For treatment of HIV infection: Adults—One tablet once a day with food. Children weighing 25 kilograms (kg) or more—One ...

  8. Aspirin and omeprazole (oral route) - Mayo Clinic

    This medicine may increase your risk of having fractures of the hip, wrist, and spine. This is more likely if you are 50 years of age and older, if you receive ...

  9. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

  10. A Study of Oral Kavalactones Effect on Nurses - Mayo Clinic

    The purpose of this study is to assess the effect of 4 weeks of kavalactone dosing on cortisol in a healthy nursing population. Secondary aims will assess ...